Mukund Seshadri1, David A Bellnier, Richard T Cheney. 1. Preclinical Imaging Resource, Cancer Cell Center, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. mukund.seshadri@roswellpark.org
Abstract
PURPOSE: To investigate the early effects of a vascular disrupting agent (VDA) in ectopic and orthotopic tumors by using macromolecular contrast media (MMCM)-enhanced magnetic resonance imaging (MMCM-MRI). METHODS AND MATERIALS: The MMCM-MRI of ectopic and orthotopic MCA205 murine fibrosarcomas was performed using the intravascular contrast agent albumin-(gadopentetate dimeglumine)(35). Change in longitudinal relaxation rate (DeltaR1) was measured 24 hours after treatment with 5,6-dimethylxanthenone-4-acetic acid (DMXAA; 30 mg/kg) and used to compute tumor vascular volume and permeability. Correlative histologic and immunohistochemical evaluation was carried out, along with measurement of tumor necrosis factor alpha and vascular endothelial growth factor levels in whole tumor extracts using the enzyme-linked immunosorbent assay. RESULTS: Orthotopic tumors showed higher vascular volume (p < 0.05) than ectopic tumors before treatment. Twenty-four hours after DMXAA treatment, a significant (p < 0.0001), but differential, decrease in DeltaR1 (70% in ectopic and 50% in orthotopic tumors) was observed compared with baseline estimates. Consistent with this observation, greater levels of tumor necrosis factor alpha, an important mediator of the antivascular activity of DMXAA, were measured in ectopic tumors 3 hours posttreatment compared with orthotopic tumors (p < 0.05). Immunohistochemical (CD31) and histologic (hematoxylin and eosin) sections of ectopic and orthotopic tumors showed highly tumor-selective vascular damage after treatment with the presence of viable surrounding normal tissue. CONCLUSIONS: The MMCM-MRI provided early quantitative estimates of change in tumor perfusion after VDA treatment that showed good correlation with cytokine induction. Differences in the response of ectopic and orthotopic tumors highlight the influence of the host microenvironment in modulating the activity of VDAs.
PURPOSE: To investigate the early effects of a vascular disrupting agent (VDA) in ectopic and orthotopic tumors by using macromolecular contrast media (MMCM)-enhanced magnetic resonance imaging (MMCM-MRI). METHODS AND MATERIALS: The MMCM-MRI of ectopic and orthotopic MCA205 murinefibrosarcomas was performed using the intravascular contrast agent albumin-(gadopentetate dimeglumine)(35). Change in longitudinal relaxation rate (DeltaR1) was measured 24 hours after treatment with 5,6-dimethylxanthenone-4-acetic acid (DMXAA; 30 mg/kg) and used to compute tumor vascular volume and permeability. Correlative histologic and immunohistochemical evaluation was carried out, along with measurement of tumor necrosis factor alpha and vascular endothelial growth factor levels in whole tumor extracts using the enzyme-linked immunosorbent assay. RESULTS:Orthotopic tumors showed higher vascular volume (p < 0.05) than ectopic tumors before treatment. Twenty-four hours after DMXAA treatment, a significant (p < 0.0001), but differential, decrease in DeltaR1 (70% in ectopic and 50% in orthotopic tumors) was observed compared with baseline estimates. Consistent with this observation, greater levels of tumor necrosis factor alpha, an important mediator of the antivascular activity of DMXAA, were measured in ectopic tumors 3 hours posttreatment compared with orthotopic tumors (p < 0.05). Immunohistochemical (CD31) and histologic (hematoxylin and eosin) sections of ectopic and orthotopic tumors showed highly tumor-selective vascular damage after treatment with the presence of viable surrounding normal tissue. CONCLUSIONS: The MMCM-MRI provided early quantitative estimates of change in tumor perfusion after VDA treatment that showed good correlation with cytokine induction. Differences in the response of ectopic and orthotopic tumors highlight the influence of the host microenvironment in modulating the activity of VDAs.
Authors: R Brasch; C Pham; D Shames; T Roberts; K van Dijke; N van Bruggen; J Mann; S Ostrowitzki; O Melnyk Journal: J Magn Reson Imaging Date: 1997 Jan-Feb Impact factor: 4.813
Authors: N Watanabe; Y Niitsu; H Umeno; H Kuriyama; H Neda; N Yamauchi; M Maeda; I Urushizaki Journal: Cancer Res Date: 1988-04-15 Impact factor: 12.701
Authors: Y D Jung; S A Ahmad; Y Akagi; Y Takahashi; W Liu; N Reinmuth; R M Shaheen; F Fan; L M Ellis Journal: Cancer Metastasis Rev Date: 2000 Impact factor: 9.264
Authors: Anda Preda; Viktor Novikov; Martina Möglich; Karl Turetschek; David M Shames; Robert C Brasch; Friedrich M Cavagna; Timothy P L Roberts Journal: J Magn Reson Imaging Date: 2004-11 Impact factor: 4.813
Authors: Karl Turetschek; Anda Preda; Viktor Novikov; Robert C Brasch; Hanns J Weinmann; Patrick Wunderbaldinger; Timothy P L Roberts Journal: J Magn Reson Imaging Date: 2004-07 Impact factor: 4.813
Authors: Susan M Galbraith; Ross J Maxwell; Martin A Lodge; Gillian M Tozer; John Wilson; N Jane Taylor; J James Stirling; Luiza Sena; Anwar R Padhani; Gordon J S Rustin Journal: J Clin Oncol Date: 2003-06-13 Impact factor: 44.544
Authors: Ravikumar Aalinkeel; Bindukumar Nair; Chih-Kuang Chen; Supriya D Mahajan; Jessica L Reynolds; Hanguang Zhang; Haotian Sun; Donald E Sykes; Kailash C Chadha; Steven G Turowski; Katelyn D Bothwell; Mukund Seshadri; Chong Cheng; Stanley A Schwartz Journal: Immunology Date: 2016-08 Impact factor: 7.397
Authors: Jong Cheol Lee; Ho Yong Lee; Chang Hoon Moon; Seung Ju Lee; Won Hyeok Lee; Hee Jeong Cha; Sungchan Park; Young Han Lee; Hyun Jin Park; Ho-Taek Song; Young Joo Min Journal: Transl Oncol Date: 2013-02-01 Impact factor: 4.243
Authors: Christoph Oehler; Joseph A O'Donoghue; James Russell; Pat Zanzonico; Sylvie Lorenzen; C Clifton Ling; Sean Carlin Journal: J Nucl Med Date: 2011-02-14 Impact factor: 10.057
Authors: Dušan Milanović; Friederike Braun; Wolfgang Weber; Anca Ligia Grosu; Martin Behe; Gabriele Niedermann Journal: BMC Cancer Date: 2012-06-13 Impact factor: 4.430
Authors: Chang Hoon Moon; Seung Ju Lee; Ho Yong Lee; Jong Cheol Lee; Heejeong Cha; Wha Ja Cho; Jeong Woo Park; Hyun Jin Park; Jin Seo; Young Han Lee; Ho-Taek Song; Young Joo Min Journal: PLoS One Date: 2013-01-11 Impact factor: 3.240